DIRS.INFO The most relevant business & tech news

☆ Two health-care stocks are in the headlines. How the news impacts our investments
▼ + stars: | 2023-07-07 | by ( Kevin Stankiewicz | In Kevinstankiewicz | ) www.cnbc.com time to read: +9 min

Here's a deeper look at the headlines and their implications for our investment theses in these two health-care companies. The Club's take: The first-of-their-kind FDA and CMS actions came in generally as anticipated, and represent incremental positives for Eli Lilly. That's why some of the decline seen Friday in Eli Lilly shares – down over 2%, to around $453 each – could simply represent a sell-the-news situation. Eli Lilly has said donanemab could be approved by the FDA late this year or in early 2024. Our expectations around donanemab sales also are measured, and the drug is not the primary driver of our multiyear optimism for Eli Lilly.

Persons: Eli Lilly, Eli Lilly's donanemab, Leqembi —, Biogen, —, Lilly's, That's, Donanemab, Lilly, donanemab, that's, Lisa Gill, UnitedHealth, Humana, Gill, What's, We'll, Jim Cramer's, Jim Cramer, Jim Organizations: Club, Drug Administration, Medicare, Medicaid Services, FDA, GE Healthcare, Humana, JPMorgan, CNBC Locations: Massachusetts

☆ UnitedHealth bags Amedisys for $3.3 bln as home health firm scraps Option deal
▼ + stars: | 2023-06-26 | by ( ) www.reuters.com time to read: +1 min

June 26 (Reuters) - Home health and hospice caregiver Amedisys (AMED.O) on Monday agreed to a $3.3 billion sweetened cash offer from UnitedHealth Group (UNH.N) and scrapped an all-stock deal with Option Care Health (OPCH.O). Meanwhile, Option Care said it was "disappointed" with the cancellation of the deal and will get $106 million from Amedisys as per its May agreement. Option Care shares rose 3% in early trading, while those of Amedisys and UnitedHealth were largely flat. Option Care investors had largely disapproved of its deal for Amedisys as they believed the company was capable of recording strong growth on its own. Its shares had slumped 14% in May due to the Amedisys deal, but rose nearly 10% this month after UnitedHealth entered the race.

Persons: Amedisys, UnitedHealth, William Blair, Matt Larew, Leroy Leo, Saumyadeb Chakrabarty, Arun Koyyur Organizations: UnitedHealth, Care, LHC, Amedisys, Thomson Locations: Amedisys, Bengaluru

The 8-1 ruling, written by liberal Justice Elena Kagan, upheld a lower court's decision to allow the Justice Department to toss a lawsuit against a UnitedHealth Group Inc (UNH.N) unit by a former employee named Jesse Polansky who accused it of wrongdoing. Polansky had sought to bar the department from dismissing whistleblower lawsuits filed under the False Claims Act in instances in which the government initially declined to exercise its right to take over the cases. Whistleblower cases brought under the False Claims Act resulted in $48.2 billion in recoveries from 1987 to 2021, according to Justice Department data. The Justice Department sought dismissal of Polansky's lawsuit in 2019, citing concerns including the "tremendous" burden of requests for the government to produce documents. The Supreme Court on June 1 ruled in another whistleblowers case involving the False Claims Act.

Persons: Department's, Elena Kagan, Jesse Polansky, Polansky, Polansky's, Kagan, Clarence Thomas, Donald Trump's, Nate Raymond, John Kruzel, Will Dunham Organizations: U.S, Supreme, Justice Department, Circuit, Health Resources, Conservative, Department, U.S . Chamber, Commerce, Republican, The Justice, Thomson Locations: Philadelphia, Boston, Washington

REUTERS/Mike Blake/File Photo/File PhotoJune 14 (Reuters) - Health insurer stocks dropped sharply on Wednesday after UnitedHealth Group (UNH.N) said costs were on the rise for the largest U.S. healthcare provider by market value due to an increase in surgeries among older adults. Shares of industry bellwether UnitedHealth fell 7.3% to $455.11, wiping out roughly $42 billion from the company's market capitalization in the current trading session. Meanwhile, stocks of medical device makers and hospital operators rose, as increased frequency of surgeries mean more revenue for them. The company highlighted strong demand for hip and knee procedures at outpatient centers, as well as for home health services and behavioral services. Elevance Health (ELV.N), CVS Health Corp (CVS.N), Centene Corp (CNC.N) and Cigna Group (CI.N) fell between 6% and 7.5%.

Persons: Mike Blake, bellwether, UnitedHealth, Jefferies, Brian Tanquilut, Zimmer Biomet, Leroy Leo, Bhanvi, Manas Mishra, Shinjini Organizations: REUTERS, UnitedHealth, Medicare, Humana Inc, Reuters Graphics, Elevance, CVS Health Corp, Centene Corp, Cigna, Elevance Health Inc, CVS, Healthcare, Tenet Healthcare, Stryker, Thomson Locations: Santa Ana , California, U.S, Bengaluru

☆ UnitedHealth falls on warning of higher medical costs, drags down rivals
▼ + stars: | 2023-06-14 | by ( Leroy Leo | ) www.reuters.com time to read: +2 min

The warning also dragged down shares of rival health insurers that largely benefited from delayed non-urgent surgeries such as hip and knee replacements and hospital staffing shortages that had further led to fewer procedures. UnitedHealth, at a Goldman Sachs healthcare conference, highlighted elevated demand for outpatient medical procedures, particularly related to knees and hips, from patients in Medicare health plans meant for those aged 65 and above. UnitedHealth also expects its full-year medical loss ratio at the upper end of its forecast. UnitedHealth's 18.51 forward 12-month price-to-earnings ratio - a common benchmark for valuing stocks - is higher than rival Cigna Corp's (CI.N) 10.29 and CVS Health Corp (CVS.N) 8.26. Shares of Humana Inc (HUM.N) fell 7%, while Elevance Health and CVS Health Corp's (CVS.N) fell more than 3% each in premarket trading.

Persons: Goldman Sachs, Tim Noel, UnitedHealth, Julie Utterback, Cigna Corp's, Leroy Leo, Shinjini Organizations: UnitedHealth, Goldman, CVS Health Corp, Humana Inc, Elevance, CVS Health, Thomson Locations: Bengaluru

☆ Health insurance stocks slide after UnitedHealth warns more surgeries will drive up medical costs
▼ + stars: | 2023-06-14 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +1 min

Health insurer stocks dropped on Wednesday after UnitedHealth Group warned of higher medical costs as older Americans start to catch up on surgeries they delayed during the Covid pandemic. Shares of UnitedHealth, the largest U.S. healthcare provider by market value, closed around 6% lower. Elevance Health closed roughly 7% lower, and CVS Health , which owns the insurer Aetna, slid nearly 8%. The company has recorded "strong outpatient care activity" throughout April, May and the early part of June, CFO John Rex said at a Goldman Sachs healthcare conference. Shares of medical device manufacturers Medtronic and Stryker jumped 2.5% and 4%, respectively, after UnitedHealth's remarks.

Persons: UnitedHealth, John Rex, Goldman Sachs, Medicare enrollees, Rex, Timothy Noel, Stryker, UnitedHealth's Organizations: UnitedHealth, Medicare, Humana, Elevance Health, CVS Health, Aetna, Insurance, Goldman, Healthcare, Tenet Healthcare

☆ UnitedHealth offers over $3 bln for home health firm Amedisys
▼ + stars: | 2023-06-05 | by ( Leroy Leo | ) www.reuters.com time to read: +2 min

June 5 (Reuters) - UnitedHealth Group (UNH.N) on Monday made a surprise $3.26 billion all-cash offer to acquire Amedisys Inc (AMED.O), pitting itself against another healthcare company set to buy the home health and hospice care firm. UnitedHealth, through its Optum unit, offered to pay $100 per share in cash, just a month after Amedisys agreed to be bought by Option Care Health Inc (OPCH.O) for $97.38 per share in an all-stock deal. If Optum's offer is accepted by Amedisys, the deal will expand UnitedHealth's presence in home healthcare that it bolstered this year through a $5.4 billion deal to buy Amedisys' rival, LHC Group. Several analysts raised concerns that a UnitedHealth deal would likely face scrutiny from the Federal Trade Commission, given UnitedHealth's home health presence. Amedisys' board has not yet determined whether Optum's offer is superior to Option Health's and is currently in exploratory discussions with the UnitedHealth unit.

Persons: Amedisys, Jefferies, Brian Tanquilut, Oppenheimer, Michael Wiederhorn, Leroy Leo, Shounak Dasgupta, Shinjini Organizations: UnitedHealth, Amedisys Inc, Care Health Inc, LHC, Federal Trade Commission, FTC, Care, Thomson Locations: Bengaluru

☆ How UnitedHealth Group grew bigger than the nation's biggest banks
▼ + stars: | 2023-05-20 | by ( Charlotte Morabito | In Charlottemorabito | ) www.cnbc.com time to read: +3 min

UnitedHealth Group has the highest price per share of any company on the Dow Jones Industrial Average and it's the tenth heaviest-weighted stock on the S&P 500. In fact, not only is UnitedHealth the biggest health-care conglomerate in the United States based on market cap and revenue, it's even bigger than JPMorgan Chase, the nation's largest bank. "If I had to pick one stock, only one stock to buy, I'd buy United[Health]," said Ana Gupte, principal at AG Health Advisors. "UnitedHealth Group is committed to improving the health system for everyone, advancing evidence-based practice and aligning incentives across the system to ensure people get the right care at the right time in the right place," UnitedHealth Group told CNBC. Watch the video above to learn how UnitedHealth Group grew so big and what that means for the U.S. health-care system.

☆ Raymond James' John Ransom weighs in on UnitedHealth's earnings beat
▼ + stars: | 2023-04-14 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailRaymond James' John Ransom weighs in on UnitedHealth's earnings beatCNBC's Bertha Coombs with John Ransom, Raymond James, joins 'The Exchange' to discuss UnitedHealth.

☆ UnitedHealth raises profit view on Medicare Advantage strength
▼ + stars: | 2023-04-14 | by ( ) www.cnbc.com time to read: +1 min

UnitedHealth Group beat Wall Street targets for quarterly profit and raised its annual forecast on Friday, as the health insurance provider banks on membership growth in its Medicare Advantage business. Memberships in government-backed plans such as Medicare - which offers healthcare coverage for people aged 65 and older or those with certain disabilities - make up one-third of UnitedHealth's health insurance plans. A slow recovery in non-urgent procedures helped lower medical costs at its insurance unit, driving the company's first-quarter profit above expectations. UnitedHealth raised its 2023 profit forecast to between $24.50 and $25.00 per share on an adjusted basis, higher than its earlier estimate of $24.40 to $24.90. Excluding items, the company reported a profit of $6.26 per share for the first quarter, beating estimates of $6.13.

☆ Three stocks making big moves Friday: BA, UNH, and JPM
▼ + stars: | 2023-04-14 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailThree stocks making big moves Friday: BA, UNH, and JPMShelby McFaddin, an investment analyst at Motley Fool Asset Management, joins 'Power Lunch' to discuss Boeing's shares sliding over 737 delays, UnitedHealth's fundamentals, and JPMorgan delivering impressive deposit growth.

UnitedHealth has by far the biggest weighting in the Dow Jones Industrial Average . The 126-year-old blue-chip benchmark is price-weighted, meaning stocks with higher share prices are given the most weight. The health-care stock closed Wednesday at $520.97, while the stock with the second-highest impact on the 30-stock Dow, Goldman Sachs , stood at $327.37, nearly $200 less than UnitedHealth. While almost all other equity indexes are weighted by market capitalization, including the S & P 500 and the Nasdaq Composite , that doesn't mean UnitedHealth's power is diminished. The insurer is so large, with a $486 billion market cap, it ranks as the ninth-biggest company in the S & P 500.

☆ Morgan Stanley named this health stock a top pick because of its business diversification
▼ + stars: | 2023-04-11 | by ( Alex Harring | ) www.cnbc.com time to read: +2 min

UnitedHealth 's business diversification and positioning within Medicare can take the health insurance giant a long way, according to Morgan Stanley. Analyst Erin Wright switched her top pick to UnitedHealth from Cigna in the health care facilities and managed care space. And within Optum's 56% share, she said earnings are evenly split between the company's health care, prescription and technology arms. She noted that UnitedHealth's earnings were closer to 90% from health insurance and 10% from Optum 10 year ago. (Medicare Advantage provides a way to get benefits from the "A" and "B" parts of Medicare.)

☆ UnitedHealth can estimate 13-16% EPS growth and they won't miss that: Raymond James' Ransom
▼ + stars: | 2023-04-11 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailUnitedHealth can estimate 13-16% EPS growth and they won't miss that: Raymond James' RansomJohn Ransom, Raymond James managing director of healthcare equity research, joins 'Power Lunch' to discuss what's at stake in UnitedHealth's earnings results, how long the company can continue to grow and more.

☆ Justice Department sues to block JetBlue’s acquisition of Spirit Airlines
▼ + stars: | 2023-03-07 | by ( Leslie Josephs | ) www.cnbc.com time to read: +3 min

The Justice Department on Tuesday sued to block JetBlue Airways ' $3.8 billion proposed takeover of budget carrier Spirit Airlines , the Biden administration's latest attempt to prevent industry consolidation. Spirit Airlines agreed to sell itself to JetBlue last summer after a long battle for the carrier between JetBlue and Frontier Airlines . A JetBlue-Spirit combination would be the first major U.S. airline merger since Alaska Airlines' takeover of Virgin America in 2016. The Justice Department at the time required Alaska to scale back its code share with American Airlines to clear the deal. Separately, JetBlue is awaiting a ruling on its Northeast partnership with American Airlines, which the Justice Department sued to undo in 2021.

☆ Factbox: Which CVS rivals also own primary care services
▼ + stars: | 2023-02-08 | by ( ) www.reuters.com time to read: +2 min

Here is a list of some big companies that are also providing medical services or have announced similar deals:UnitedHealth Group IncUnitedHealth's (UNH.N) Optum Health business provides services that range from primary care to specialty care such as cardiology and oncology. UnitedHealth last year also announced a deal to buy LHC Group (LHCG.O), which provides healthcare services at home, for about $5.4 billion. Walgreens Boots AlliancePharmacy chain Walgreens (WBA.O) in 2021 took a majority stake in primary care provider VillageMD, which has nearly 400 clinics in the United States including 200 co-located with Walgreens retails stores, as of the end of 2022. VillageMD completed the acquisition of urgent care provider Summit Health in a deal valued at $9 billion. Amazon.com IncAmazon.com Inc (AMZN.O) agreed to buy primary care provider One Medical for $3.49 billion in July to expand its virtual healthcare and add brick-and-mortar doctors' offices.

☆ UnitedHealth quarterly profit beats as medical costs stay low
▼ + stars: | 2023-01-13 | by ( ) www.reuters.com time to read: +1 min

Companies UnitedHealth Group Inc FollowJan 13 (Reuters) - UnitedHealth Group Inc (UNH.N) on Friday reported a quarterly profit that beat Wall Street estimates, helped by lower medical costs and a boost from its Optum health services unit, which operates the company's pharmacy benefit management business. Health insurers' costs have been in flux during the pandemic, but have eased over the past year as COVID-related hospitalizations have fallen from their peak. Revenue from Optum rose 16.5% to $47.87 billion, aided by strong growth in its health service and pharmacy benefit management business. Optum includes the company's pharmacy benefit management business that helps negotiate the terms of coverage between health insurers, their clients and drug manufacturers. Reporting by Leroy Leo and Khushi Mandowara in Bengaluru; Editing by Shailesh KuberOur Standards: The Thomson Reuters Trust Principles.

☆ Justice Department's fight with JetBlue and American Airlines heads to court
▼ + stars: | 2022-09-27 | by ( Leslie Josephs | ) www.cnbc.com time to read: +4 min

An American Airlines plane lands on a runway near a parked JetBlue plane at the Fort Lauderdale-Hollywood International Airport on July 16, 2020 in Fort Lauderdale, Florida. The Justice Department heads to court in Boston on Tuesday in hopes of undoing a year-and-a-half-old pact between American Airlines and JetBlue Airways in the Northeast U.S. Last September, the Justice Department along with the attorneys general of six states and the District of Columbia sued to block the partnership, which was approved in the final days of the Trump administration. The antitrust trial will be a test for President Joe Biden's Justice Department, which has been tasked with taking a hard stance against threats to competition. Earlier this month, a federal judge denied the Justice Department's bid to block UnitedHealth's acquisition of Change Healthcare.

☆ Stocks making the biggest moves in the premarket: Ford, Change Healthcare, Cognex and more
▼ + stars: | 2022-09-20 | by ( Peter Schacknow | ) www.cnbc.com time to read: +2 min

Take a look at some of the biggest movers in the premarket:Ford (F) – The automaker's stock fell 4.5% in the premarket after it warned that quarterly earnings would take a hit of about $1 billion from increased supplier costs and parts shortages. BioNTech fell 2.4% in premarket trading, with Moderna off by 2.1%. Cognex (CGNX) – Cognex shares jumped 4.7% in the premarket after the maker of machine vision systems and sensors raised its current-quarter revenue outlook. Western Digital (WDC) – The disk drive maker's shares fell 1.7% in the premarket following a downgrade by Deutsche Bank to "hold" from "buy." Deutsche Bank said the company's profit and revenue appear to be coming in at the low end of guidance due to deteriorating demand.

☆ Judge denies DOJ request to block UnitedHealth-Change acquisition
▼ + stars: | 2022-09-20 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailJudge denies DOJ request to block UnitedHealth-Change acquisitionA U.S. judge has denied the Justice Department's effort to block UnitedHealth's bid to buy Change Healthcare. CNBC's David Faber breaks down the details.

Search resuls for: "UnitedHealth's"

20 mentions found